Product Program year 2021 Source: CMS Open Payments

Proclaim DRG IPG

Device Neuromodulation

PDI 05415067020215

Open in the dashboard

General payments

$575,286

3,078 payments

Research payments

$304,918

219 payments

Through program year 2021, $575,286 in general payments and $304,918 in research payments were reported against Proclaim DRG IPG (Neuromodulation).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2021 General $575,286 3,078
2021 Research $304,918 219

Breakdown

Who paid General payments · program year 2021
  1. Abbott Laboratories $575,286 3,078 payments
Top recipients General payments · program year 2021
  1. Steven Falowski Neurological Surgery · Fountain Hill, PA $89,111 15% · 46 payments
  2. Timothy Deer Interventional Pain Medicine · Charleston, WV $56,491 10% · 37 payments
  3. Pankaj Mehta Interventional Pain Medicine · Killeen, TX $52,371 9% · 24 payments
  4. Jeffery Rowe Physical Medicine & Rehabilitation · King Of Prussia, PA $38,743 7% · 27 payments
  5. Jason Pope Pain Medicine · Santa Rosa, CA $25,285 4% · 16 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Interventional Pain Medicine Pain Medicine $189,283 33% · 186 practitioners
  2. Pain Medicine Anesthesiology $110,286 19% · 203 practitioners
  3. Neurological Surgery $101,277 18% · 50 practitioners
  4. Physical Medicine & Rehabilitation $54,867 10% · 64 practitioners
  5. Anesthesiology $32,514 6% · 73 practitioners

The top 5 of 60 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. Pennsylvania $135,562 24% · 57 recipients
  2. West Virginia $70,519 12% · 11 recipients
  3. Texas $63,437 11% · 107 recipients
  4. California $61,622 11% · 95 recipients
  5. New York $42,480 7% · 153 recipients

The top 5 of 48 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

3,078 general · 219 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record